Mesa Laboratories Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	20.42	27.32	28.21	32.91	49.35	263.87
Short-Term Investments	1.53	1.75	1.9	-	-	-
Cash & Short-Term Investments	21.95	29.07	30.11	32.91	49.35	263.87
Cash Growth	-15.59%	-3.45%	-8.50%	-33.31%	-81.30%	224.24%
Receivables	40.09	41.97	39.06	42.55	41.22	23.79
Inventory	27.74	25.37	32.68	34.64	24.61	11.18
Prepaid Expenses	3.54	2.36	2.93	8.87	9.14	4.92
Other Current Assets	4.11	3.91	4.58	-	-	-
Total Current Assets	97.43	102.69	109.35	118.98	124.32	303.75
Property, Plant & Equipment	31.84	48.72	41.44	36.84	38.82	23.8
Goodwill	188.49	181.76	180.1	286.44	291.17	160.84
Other Intangible Assets	93.27	96.88	113.75	216.82	250.12	111.74
Long-Term Deferred Tax Assets	1.47	1.37	1.29	1.08	1.32	0.62
Other Long-Term Assets	17.86	1.94	0.87	1.68	1.63	0.73
Total Assets	430.35	433.35	446.8	661.83	707.37	601.48
Accounts Payable	5.09	5.75	6.04	6.13	7.9	4.47
Accrued Expenses	19.01	27.46	18.19	17.67	21.88	16.15
Current Portion of Long-Term Debt	4.69	101.05	-	-	-	-
Current Portion of Leases	3.82	3.52	2.99	2.87	2.77	1.02
Current Income Taxes Payable	1.43	2.16	1.62	0.99	0.93	1.65
Current Unearned Revenue	14.26	14.71	15.48	15.69	13.83	8.78
Other Current Liabilities	-	9.32	-	-	0.75	0.51
Total Current Liabilities	48.3	163.96	44.31	43.36	48.06	32.58
Long-Term Debt	170.16	76.9	221.7	183.27	218.37	145.68
Long-Term Leases	-	12.38	6.61	5.75	7.44	0.68
Long-Term Unearned Revenue	0.01	0.09	0.21	0.4	-	-
Long-Term Deferred Tax Liabilities	21.66	20.18	19.78	34.03	39.22	16.28
Other Long-Term Liabilities	11.75	-	8.79	1.54	0.49	0.04
Total Liabilities	251.88	273.52	301.4	268.35	313.57	195.25
Common Stock	365.17	358.54	343.64	332.08	313.46	317.65
Retained Earnings	-183.47	-188.94	-183.49	74.2	76.68	72.46
Comprehensive Income & Other	-3.23	-9.78	-14.76	-12.8	3.67	16.12
Shareholders' Equity	178.47	159.83	145.39	393.48	393.8	406.23
Total Liabilities & Equity	430.35	433.35	446.8	661.83	707.37	601.48
Total Debt	178.67	193.85	231.3	191.89	228.57	147.38
Net Cash (Debt)	-156.72	-164.78	-201.19	-158.98	-179.22	116.49
Net Cash Per Share	-28.69	-30.40	-37.35	-29.66	-33.59	22.73
Filing Date Shares Outstanding	5.52	5.46	5.41	5.37	5.27	5.14
Total Common Shares Outstanding	5.51	5.46	5.39	5.37	5.27	5.14
Working Capital	49.14	-61.28	65.04	75.62	76.26	271.17
Book Value Per Share	32.39	29.30	26.95	73.28	74.79	79.02
Tangible Book Value	-103.29	-118.81	-148.46	-109.78	-147.48	133.65
Tangible Book Value Per Share	-18.74	-21.78	-27.52	-20.45	-28.01	26.00
Land	-	0.89	0.89	0.89	0.89	0.89
Buildings	-	23.28	23.48	22.01	21.54	18.86
Machinery	-	25.79	23.15	18.89	21.86	16.51
Construction In Progress	-	1.61	1.38	1.74	0.49	0.99
Order Backlog	-	43.2	25.5	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.